ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,602Medicare Part D Prescriptions Filled, Including Refills

Rank: 317 out of 890

$366K Total Retail Price of All Prescriptions

Rank: 357 out of 890

278 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 278 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,150 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 379 296 1 2
LOVASTATIN 257 207 2 46
METOPROLOL TARTRATE 244 216 3 15
AMLODIPINE BESYLATE 209 185 4 1
SIMVASTATIN 185 155 5 5
HYDROCODONE-ACETAMINOPHEN 183 132 S3 6 3
FUROSEMIDE 178 163 7 7
LISINOPRIL 146 122 8 4
OMEPRAZOLE 142 124 9 8
ISOSORBIDE MONONITRATE ER 130 127 10 60
POTASSIUM CHLORIDE 126 113 11 11
ALENDRONATE SODIUM 125 104 12 38
METFORMIN HCL 123 111 13 6
RANITIDINE HCL 121 118 14 49
ATENOLOL 110 84 15 23
GABAPENTIN 108 76 16 12
PAROXETINE HCL 105 66 17 68
PRAVASTATIN SODIUM 105 91 17 10
HYDRALAZINE HCL 102 95 19 100
METOPROLOL SUCCINATE 101 101 20 17
WARFARIN SODIUM 98 77 21 24
PREDNISONE 90 75 22 47
ZOLPIDEM TARTRATE 84 50 23 19
ALLOPURINOL 82 53 24 31
METFORMIN HCL ER 80 57 25 54
CIPROFLOXACIN HCL 77 65 26 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 44 27 21
MELOXICAM 75 31 28 18
ENALAPRIL MALEATE 74 73 29 56
LOSARTAN POTASSIUM 73 44 30 29
FLUTICASONE PROPIONATE 72 55 31 39
CLOPIDOGREL 72 57 31 28
CITALOPRAM HBR 70 38 33 20
NEXIUM 58 29 34 14
TRAMADOL HCL 54 44 35 16
CLONIDINE HCL 54 40 35 35
GLIMEPIRIDE 53 33 37 27
DONEPEZIL HCL 52 52 38 30
FLUOXETINE HCL 51 48 39 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.